Entero Healthcare Solutions Fair Value
Entero Healthcare Solutions (ENTERO) average fair value is ₹491.14 across 7 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Earnings Growth Model (PEG), Peter Lynch Fair Value, Benjamin Graham Number, vs a current market price of ₹1229.6 (-60.06%), fair value range ₹23.47–₹1324.4.
Fair Value Analysis Export
ENTERO Fair Value vs Current Price — Valuation Summary
ENTERO average fair value, fair value range, price gap and valuation status across 7 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Earnings Growth Model (PEG), Peter Lynch Fair Value, Benjamin Graham Number. For live price and a broader fundamental view, visit Entero Healthcare Solutions share price screener.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Earnings Growth Model (PEG)
Peter Lynch Fair Value
Benjamin Graham Number
ENTERO Fair Value Analysis — Data Sources & Coverage
Entero Healthcare Solutions financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year. Check ENTERO market cap trends to track the company's total market size over time.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
Data Currency: Financial data is from the current year (2026).
ENTERO vs Retail Sector Peers — P/E, P/B & Market Cap
Entero Healthcare Solutions P/E ratio, P/B ratio and market capitalisation vs Retail sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Future Enterprises DVR | FELDVR | - | 0.07 | ₹10 |
| Jay Jalaram Technologies | KORE | 18.28 | 2.25 | ₹199 |
| Meesho | MEESHO | -65.17 | 20.16 | ₹87,308 |
| Lenskart Solutions | LENSKART | 190.61 | 10.92 | ₹97,255 |
| Shankara Building Produc… | SHANKARA | 87.59 | 0.75 | ₹336 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.